NLM Digital Collections

Search

Search Constraints

Start Over You searched for: Recently Added Within 6 Months Remove constraint Recently Added: Within 6 Months Copyright Public domain Remove constraint Copyright: Public domain
Number of results to display per page

Search Results

2. Rabies in man

nlm:nlmuid-7602415A-vid

9. Use of serological tests to reduce the risk of transfusion-transmitted human T-lymphotropic virus types I and II (HTLV-I/II)

nlm:nlmuid-101772582-pdf

12. Recommendations for clinical laboratory improvement amendments of 1988 (CLIA) waiver applications for manufacturers of in vitro diagnostic devices: guidance for industry and Food and Drug Administration staff

nlm:nlmuid-101772617-pdf

13. Recommendations for dual 510(k) and CLIA waiver by application studies: guidance for industry and Food and Drug Administration staff

nlm:nlmuid-101772620-pdf

21. Slowly progressive, low-prevalence rare diseases with substrate deposition that result from single enzyme defects: providing evidence of effectiveness for replacement or corrective therapies

nlm:nlmuid-101772671-pdf

23. Policy for certain REMS requirements during the COVID-19 public health emergency: guidance for industry and health care professionals

nlm:nlmuid-101772699-pdf

25. Enforcement policy for sterilizers, disinfectant devices, and air purifiers during the coronavirus disease 2019 (COVID-19) public health emergency: guidance for industry and Food and Drug Administration staff

nlm:nlmuid-101772705-pdf

26. Enforcement policy for gowns, other apparel, and gloves during the coronavirus disease (COVID-19) public health emergency: guidance for industry and Food and Drug Administration staff

nlm:nlmuid-101772730-pdf

27. Enforcement policy for ventilators and accessories and other respiratory devices during the coronavirus disease 2019 (COVID-19) public health emergency: guidance for industry and Food and Drug Administration staff

nlm:nlmuid-101772749-pdf

49. Changes in home health care use in Medicare Advantage compared to traditional Medicare: 2011--2016

nlm:nlmuid-101775106-pdf

50. Advance care planning among Medicare fee-for-service beneficiaries and practitioners: final report

nlm:nlmuid-101775111-pdf

51. Understanding substance use coercion as a barrier to economic stability for survivors of intimate partner violence: policy implications

nlm:nlmuid-101775123-pdf

52. COVID-19 intensifies nursing home workforce challenges

nlm:nlmuid-101775124-pdf

53. Understanding the characteristics of older adults in different residential settings: data sources and trends

nlm:nlmuid-101775156-pdf

54. Understanding substance use disorder (SUD) treatment needs using assessment data: final report

nlm:nlmuid-101775160-pdf

55. Projections of poverty and program eligibility during the COVID-19 pandemic

nlm:nlmuid-101775164-pdf